Browse by Publication
![]() | Up a level |
Jump to: Article
Number of items: 11.
Article
Chan, CW;
Gunsar, F;
Feudjo, M;
Rigamonti, C;
Vlachogiannakos, J;
Carpenter, JR;
Burroughs, AK;
(2005)
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Alimentary pharmacology & therapeutics, 21 (3).
pp. 217-26.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2005.02318.x
Full text not available from this repository.
Chan, CW;
Tsochatzis, EA;
Carpenter, JR;
Rigamonti, C;
Gunsar, F;
Burroughs, AK;
(2010)
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach.
Alimentary pharmacology & therapeutics, 31 (5).
pp. 573-582.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2009.04215.x
Full text not available from this repository.
Fleming, KM;
West, J;
Aithal, GP;
Fletcher, AE;
(2011)
Abnormal liver tests in people aged 75 and above: prevalence and association with mortality.
Alimentary pharmacology & therapeutics, 34 (3).
pp. 324-34.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2011.04718.x
Full text not available from this repository.
Hart, J;
Hawkey, CJ;
Lanas, A;
Naesdal, J;
Talley, NJ;
Thomson, AB;
Yeomans, ND;
(2010)
Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
Alimentary pharmacology & therapeutics, 31 (1).
pp. 143-9.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2009.04133.x
Full text not available from this repository.
Lemoine, M;
Shimakawa, Y;
Nayagam, S;
Njie, R;
Thursz, M;
(2013)
Commentary: how long does one need to fast before a Fibroscan examination? Authors' reply.
Alimentary pharmacology & therapeutics, 39 (5).
pp. 541-542.
ISSN 0269-2813
DOI: https://doi.org/10.1111/apt.12623
Full text not available from this repository.
Lemoine, M;
Shimakawa, Y;
Njie, R;
Njai, HF;
Nayagam, S;
Khalil, M;
Goldin, R;
Ingiliz, P;
Taal, M;
Nyan, O;
+3 more...
Corrah, T;
D'Alessandro, U;
Thursz, M;
(2013)
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.
Alimentary pharmacology & therapeutics, 39 (2).
pp. 188-96.
ISSN 0269-2813
DOI: https://doi.org/10.1111/apt.12561
Full text not available from this repository.
Shack, LG;
Wood, HE;
Kang, JY;
Brewster, DH;
Quinn, MJ;
Maxwell, JD;
Majeed, A;
(2006)
Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival.
Alimentary pharmacology & therapeutics, 23 (9).
pp. 1297-306.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2006.02891.x
Full text not available from this repository.
Steel, AW;
Mela, CM;
Lindsay, JO;
Gazzard, BG;
Goodier, MR;
(2011)
Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment.
Alimentary pharmacology & therapeutics, 33 (1).
pp. 115-26.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2010.04499.x
Full text not available from this repository.
Tata, LJ;
Fortun, PJ;
Hubbard, RB;
Smeeth, L;
Hawkey, CJ;
Smith, CJP;
Whitaker, HJ;
Farrington, CP;
Card, TR;
West, J;
(2005)
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Alimentary pharmacology & therapeutics, 22 (3).
pp. 175-181.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2005.02543.x
Full text not available from this repository.
Warrington, S;
Baisley, K;
Boyce, M;
Tejura, B;
Morocutti, A;
Miller, N;
(2002)
Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects.
Alimentary pharmacology & therapeutics, 16 (7).
pp. 1301-7.
ISSN 0269-2813
DOI: https://doi.org/10.1046/j.1365-2036.2002.01292.x
Full text not available from this repository.
Williams, EA;
Stimpson, J;
Wang, D;
Plummer, S;
Garaiova, I;
Barker, ME;
Corfe, BM;
(2009)
Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Alimentary pharmacology & therapeutics, 29 (1).
pp. 97-103.
ISSN 0269-2813
DOI: https://doi.org/10.1111/j.1365-2036.2008.03848.x
Full text not available from this repository.